- Age greater than or equal to 13 years.
- Receiving CsA or tacrolimus from the time of transplantation or within 2 weeks
- Patients with a functioning allograft and a Nankivell GFR greater than or equal to 20
mL/min, within 2 weeks before randomization
- Biopsy-confirmed acute rejection within 12 weeks before randomization, that was
determined to require antirejection treatment
- Patients in whom kidney-pancreas or other multiple organ transplants have been